Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Management of Hyperglycemia in Post-Stroke Patients

Immediate Management

  • The American Heart Association recommends initiating insulin therapy at a threshold of 10 mmol/L (180 mg/dL) with a target range of 7.8-10 mmol/L (140-180 mg/dL) for critically ill stroke patients 1, 2
  • Initiate intravenous insulin therapy immediately for patients with glucose levels exceeding 10 mmol/L (180 mg/dL), targeting a blood glucose range of 7.8-10 mmol/L (140-180 mg/dL) 1, 2
  • Use regular insulin at 1 unit/mL concentration with an initial infusion rate of approximately 0.5 units/hour 3
  • Monitor blood glucose every 1-2 hours initially during the acute phase 3, 2
  • Adjust insulin infusion rate to maintain glucose between 7.8-10 mmol/L (140-180 mg/dL) 1, 2

Critical Safety Considerations

  • Avoid targeting normoglycemia or glucose <7.8 mmol/L (140 mg/dL) as this increases hypoglycemia risk without proven benefit and can cause permanent brain damage 2, 5
  • Hypoglycemia (<3.3 mmol/L or 60 mg/dL) is particularly dangerous post-stroke and must be corrected urgently if it occurs 6

Evidence-Based Rationale

  • Hyperglycemia in acute stroke is strongly associated with worse outcomes, including increased infarct volume, higher mortality, and increased risk of hemorrhagic transformation, particularly in patients receiving thrombolytic therapy 6, 2
  • The evidence-based protocol approach using IV insulin with frequent monitoring allows safe glucose reduction while avoiding dangerous hypoglycemia 4, 5, 3